These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6597704)

  • 21. Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major.
    Marcus RE; Davies SC; Bantock HM; Underwood SR; Walton S; Huehns ER
    Lancet; 1984 Feb; 1(8373):392-3. PubMed ID: 6141447
    [No Abstract]   [Full Text] [Related]  

  • 22. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH
    Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
    [No Abstract]   [Full Text] [Related]  

  • 23. Ferrioxamine excretion in iron-loaded man.
    Pippard MJ; Callender ST; Finch CA
    Blood; 1982 Aug; 60(2):288-94. PubMed ID: 7093519
    [No Abstract]   [Full Text] [Related]  

  • 24. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ
    Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of iron storage disorders.
    Halliday JW; Bassett ML
    Drugs; 1980 Sep; 20(3):207-15. PubMed ID: 7428669
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disorders of iron metabolism in liver patients].
    Stromeyer G
    Internist (Berl); 1966 Jan; 7(1):33-42. PubMed ID: 4861683
    [No Abstract]   [Full Text] [Related]  

  • 28. Iron overload: clinical and pathologic aspects in pediatrics.
    O'Brien RT
    Semin Hematol; 1977 Jan; 14(1):115-25. PubMed ID: 318765
    [No Abstract]   [Full Text] [Related]  

  • 29. Current problems of iron overload.
    Bothwell TH; Charlton RW
    Recent Results Cancer Res; 1979; 69():87-95. PubMed ID: 382311
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.
    Giordano N; Fioravanti A; Sancasciani S; Marcolongo R; Borghi C
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):961-2. PubMed ID: 6435741
    [No Abstract]   [Full Text] [Related]  

  • 31. Desferrioxamine in the management of dialysis hemosiderosis.
    Krumlovsky FA
    Int J Artif Organs; 1982 Jul; 5(4):223-5. PubMed ID: 7118282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
    Delaloye B; Magnenat P; Blanc B
    Nucl Med (Stuttg); 1967; ():97-111. PubMed ID: 5601765
    [No Abstract]   [Full Text] [Related]  

  • 33. Sideroachrestic anemia with iron loading: treatment with desferrioxamine.
    Zoller WG; Hehlmann R
    Klin Wochenschr; 1986 May; 64(9):417-22. PubMed ID: 3713111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
    Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
    Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
    Olivieri NF; Koren G; Hermann C; Bentur Y; Chung D; Klein J; St Louis P; Freedman MH; McClelland RA; Templeton DM
    Lancet; 1990 Nov; 336(8726):1275-9. PubMed ID: 1978115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term desferrioxamine therapy in thalassemia.
    Modell CB; Beck J
    Ann N Y Acad Sci; 1974; 232(0):201-10. PubMed ID: 4528634
    [No Abstract]   [Full Text] [Related]  

  • 37. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
    Cesana M; Mandelli C; Tiribelli C; Bianchi PA; Conte D
    Am J Gastroenterol; 1989 Feb; 84(2):150-2. PubMed ID: 2916524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
    Hehlmann R; Schmitz H; Krüger K
    Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detoxification in hemosiderosis.
    Simon P
    Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
    VENTURA S; COLI L
    Haematologica; 1964; 49():252-73. PubMed ID: 14217827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.